Kristen Ambrose
Svp & Chief Accounting Officer at Vertex Pharmaceuticals Inc / Ma (VRTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 2SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 357 | $483.36 | $173K | +4.2% |
| Feb 26SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 223 | $486.35 | $108K | +3.5% |
| Feb 19SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,557 | $489.46 | $762K | +2.9% |
| Feb 19SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 638 | $473.68 | $302K | +6.3% |
| Feb 12SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,376 | $460.43 | $634K | +9.4% |
- Sell
Svp & Chief Accounting Officer Kristen Ambrose sold $173K of VRTX at $483.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp & Chief Accounting Officer Kristen Ambrose sold $108K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp & Chief Accounting Officer Kristen Ambrose sold $762K of VRTX at $489.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp & Chief Accounting Officer Kristen Ambrose sold $302K of VRTX at $473.68 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp & Chief Accounting Officer Kristen Ambrose sold $634K of VRTX at $460.43 — pre-scheduled 10b5-1 plan sale.